Drug Testing Locations - Stella, LA

Drug Testing in Stella, LA

Stella, Louisiana Statistics

In 2021, Jefferson Parish, where Stella, LA is located, saw a 28% increase in opioid overdoses compared to the previous year.

Methamphetamine was the second most abused substance in Stella, LA, accounting for 23% of drug-related arrests in Jefferson Parish in 2021.

In 2020, approximately 15% of arrests in Stella, LA were related to drug trafficking incidents within Jefferson Parish.

A 2022 survey in Jefferson Parish reported that 18% of high school students admitted to using illegal drugs in the past year.

In Stella, LA, there was a 35% rise in fentanyl-related incidents reported in 2021 in Jefferson Parish.

The number of Narcan administrations in Stella, LA increased by 40% in 2021, according to Jefferson Parish emergency services.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Stella, LA & Drug Testing Policies

Many employers in Stella, LA enforce strict drug testing policies to maintain a safe and productive workplace environment. These policies align with the guidelines set forth by the Occupational Safety and Health Administration, found at OSHA.gov, ensuring businesses comply with federal standards.

Typically, employers implement pre-employment and random drug screening to deter substance abuse among employees. This not only promotes workplace safety but also reflects their commitment to community well-being. Some companies in Stella, LA also offer support programs for employees struggling with addiction, in partnership with local health services.

Government Efforts with Drug Problems in Stella, LA

The government of Jefferson Parish has been actively working to combat drug problems in Stella, LA through a variety of initiatives. Partnering with federal agencies like the Drug Enforcement Administration, local authorities focus on education and prevention programs. Additionally, state-run programs offer resources and support to individuals struggling with addiction.

Local government initiatives include public awareness campaigns and collaboration with local schools to address the issue from an early age. These efforts, supported by the Department of Health and Human Services at HHS.gov, aim to reduce drug abuse rates and provide pathways to rehabilitation for residents of Stella, LA and the surrounding Jefferson Parish.

Local Drug Busts & News in Stella, LA

Stella, LA saw a significant drug bust in 2022, with local law enforcement seizing over $1 million worth of narcotics, including methamphetamine and opioids. This operation was a part of a larger effort coordinated by regional task forces to dismantle drug trafficking networks in Jefferson Parish.

The community has hosted several drug awareness events aimed at educating residents about the dangers of substance abuse. These events, often organized by local non-profits and supported by the parish, emphasize the importance of prevention and treatment options available within Stella and Jefferson Parish.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Stella, LA. Trusted by employers nationwide for accurate results and exceptional service.

Louisiana DOT/Non DOT Physicals

Louisiana Vision Tests

Louisiana Audiograms

Louisiana Respirator Fit Tests

Louisiana Lift Tests

Louisiana Background Checks

Clinical Testing Services

TB Testing in LA

Diabetes Testing in LA

Infectious Disease Testing in LA

Sickle Cell Anemia Testing in LA

Women/Men's Health Testing in LA

Resources & Citations

OASAS

Louisiana Delta Community College

LA Addiction Help

Stop Overdose

State of Louisiana

Red Cross LA

Ascension Parish Health

Narcotics Anonymous

Drug Testing Near Stella, LA

Geismar, LA

Welcome, LA

Percle, LA

Union, LA

Modeste, LA

Lemannville, LA

Woodlawn, LA

Pierre Part, LA

Napoleonville, LA

Donaldsonville, LA

Smoke Bend, LA

Bayou Corne, LA

Belle Terre, LA

Paincourtville, LA

Belle Rose, LA

Frequently Asked Questions

Customer Reviews